Eligibility for sacubitril–valsartan in patients with acute decompensated heart failure

AIMS: Large‐scale clinical trials have demonstrated clinical benefits of sacubitril–valsartan in symptomatic heart failure with reduced ejection fraction patients (PARADIGM‐HF), with potential benefits in patients hospitalized for acute decompensated heart failure (ADHF) (PIONEER‐HF) and fewer benef...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:ESC Heart Fail
Egile Nagusiak: Carballo, David, Stirnemann, Jérôme, Garin, Nicolas, Marti, Chistophe, Serratrice, Jacques, Carballo, Sebastian
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2020
Gaiak:
Original Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7261587/
https://ncbi.nlm.nih.gov/pubmed/32167679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12676
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak